GALECTIN THERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Galectin Therapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Galectin Therapeutics Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 62.3M shares, a 0.74% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 62.3M +459K +0.74% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 62.3M +2.7M +4.53% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 62.1M +2.57M +4.31% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 61.9M +2.43M +4.08% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 61.8M +2.42M +4.08% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 59.6M +186K +0.31% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 59.6M +194K +0.33% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 59.4M +84.7K +0.14% Dec 31, 2022 10-K 2024-03-29
Q3 2022 59.4M +84.7K +0.14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 59.4M +121K +0.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 59.4M +2.2M +3.85% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 59.3M +2.26M +3.97% Dec 31, 2021 10-K 2023-03-30
Q3 2021 59.3M +2.26M +3.97% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 59.3M +2.23M +3.91% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 57.2M +157K +0.28% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 57.1M +182K +0.32% Dec 31, 2020 10-K 2022-03-31
Q3 2020 57.1M +418K +0.74% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 57M +452K +0.8% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 57M +11.4M +25.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 56.9M +15.7M +38.1% Dec 31, 2019 10-K 2021-03-31
Q3 2019 56.7M +15.5M +37.7% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 56.6M +16M +39.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.6M +7.95M +21.1% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 41.2M +5.4M +15.1% Dec 31, 2018 10-K 2020-03-16
Q3 2018 41.1M +5.5M +15.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 40.6M +5.66M +16.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 37.6M +2.98M +8.58% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 35.8M +2.88M +8.74% Dec 31, 2017 10-K 2019-03-06
Q3 2017 35.6M +6.24M +21.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 35M +5.69M +19.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 34.7M +5.69M +19.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 32.9M +4.09M +14.2% Dec 31, 2016 10-K 2018-03-29
Q3 2016 29.4M +5.47M +22.8% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 29.3M +5.49M +23.1% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 29M +5.25M +22.1% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.8M +6.55M +29.4% Dec 31, 2015 10-K 2017-03-28
Q3 2015 23.9M +1.81M +8.16% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 23.8M +1.75M +7.96% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 23.7M +1.82M +8.33% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 22.3M +3.89M +21.2% Dec 31, 2014 10-K 2016-03-15
Q3 2014 22.1M +4.47M +25.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 22M +5.74M +35.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 21.9M +5.72M +35.3% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 18.4M +2.33M +14.5% Dec 31, 2013 10-K 2015-03-18
Q3 2013 17.7M +1.68M +10.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 16.3M +480K +3.04% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 16.2M +520K +3.32% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 16.1M +3.14M +24.3% Dec 31, 2012 10-K 2014-03-21
Q3 2012 16M -60.9M -79.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 15.8M -58.2M -78.6% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 15.7M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 12.9M +2.27M +21.3% Dec 31, 2011 10-K 2013-03-29
Q3 2011 76.9M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 74.1M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 10.7M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.